These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 26162363)

  • 21. Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India.
    Maurya AK; Singh AK; Kant S; Umrao J; Kumar M; Kushwaha RA; Nag VL; Dhole TN
    Indian J Med Microbiol; 2013; 31(3):230-6. PubMed ID: 23883707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When students become patients: TB disease among medical undergraduates in Cape Town, South Africa.
    Van der Westhuizen HM; Dramowski A
    S Afr Med J; 2017 May; 107(6):475-479. PubMed ID: 28604316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost of treatment for multidrug-resistant tuberculosis in South Korea.
    Kang YA; Choi YJ; Cho YJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Respirology; 2006 Nov; 11(6):793-8. PubMed ID: 17052310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can patients afford the cost of treatment for multidrug-resistant tuberculosis in Ethiopia?
    Berhanu RH; Schnippel K; Kularatne R; Firnhaber C; Jacobson KR; Horsburgh CR; Lippincott CK
    Int J Tuberc Lung Dis; 2018 Aug; 22(8):358-362. PubMed ID: 29991400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The economic burden of TB diagnosis and treatment in South Africa.
    Foster N; Vassall A; Cleary S; Cunnama L; Churchyard G; Sinanovic E
    Soc Sci Med; 2015 Apr; 130():42-50. PubMed ID: 25681713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia.
    Floyd K; Hutubessy R; Kliiman K; Centis R; Khurieva N; Jakobowiak W; Danilovits M; Peremitin G; Keshavjee S; Migliori GB
    Eur Respir J; 2012 Jul; 40(1):133-42. PubMed ID: 22362862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
    Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
    Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High laboratory cost predicted per tuberculosis case diagnosed with increased case finding without a triage strategy.
    Dunbar R; Naidoo P; Beyers N; Langley I
    Int J Tuberc Lung Dis; 2017 Sep; 21(9):1026-1034. PubMed ID: 28826453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia.
    Eliseev P; Balantcev G; Nikishova E; Gaida A; Bogdanova E; Enarson D; Ornstein T; Detjen A; Dacombe R; Gospodarevskaya E; Phillips PP; Mann G; Squire SB; Mariandyshev A
    PLoS One; 2016; 11(4):e0152761. PubMed ID: 27055269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
    Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low treatment initiation rates among multidrug-resistant tuberculosis patients in Gauteng, South Africa, 2011.
    Ebonwu JI; Tint KS; Ihekweazu C
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1043-8. PubMed ID: 23827028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of Xpert(®) MTB/RIF in sparsely populated rural settings.
    Van Den Handel T; Hampton KH; Sanne I; Stevens W; Crous R; Van Rie A
    Int J Tuberc Lung Dis; 2015 Apr; 19(4):392-8. PubMed ID: 25859993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost outcome analysis of decentralized care for drug-resistant tuberculosis in Johannesburg, South Africa.
    van Rensburg C; Berhanu R; Hirasen K; Evans D; Rosen S; Long L
    PLoS One; 2019; 14(6):e0217820. PubMed ID: 31170207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa.
    Barnard M; Albert H; Coetzee G; O'Brien R; Bosman ME
    Am J Respir Crit Care Med; 2008 Apr; 177(7):787-92. PubMed ID: 18202343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the Xpert MTB/RIF assay for diagnosis of tuberculosis with gastric lavage aspirates in children in sub-Saharan Africa: a prospective descriptive study.
    Bates M; O'Grady J; Maeurer M; Tembo J; Chilukutu L; Chabala C; Kasonde R; Mulota P; Mzyece J; Chomba M; Mukonda L; Mumba M; Kapata N; Rachow A; Clowes P; Hoelscher M; Mwaba P; Zumla A
    Lancet Infect Dis; 2013 Jan; 13(1):36-42. PubMed ID: 23134697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Xpert MTB/RIF test for tuberculosis.
    Ferrara G; O'Grady J; Zumla A; Maeurer M
    Lancet; 2011 Aug; 378(9790):482; author reply 482-3. PubMed ID: 21821179
    [No Abstract]   [Full Text] [Related]  

  • 37. Economic evaluation of short treatment for multidrug-resistant tuberculosis, Ethiopia and South Africa: the STREAM trial.
    Madan JJ; Rosu L; Tefera MG; van Rensburg C; Evans D; Langley I; Tomeny EM; Nunn A; Phillips PP; Rusen ID; Squire SB;
    Bull World Health Organ; 2020 May; 98(5):306-314. PubMed ID: 32514196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First national tuberculosis patient cost survey in Lao People's Democratic Republic: Assessment of the financial burden faced by TB-affected households and the comparisons by drug-resistance and HIV status.
    Chittamany P; Yamanaka T; Suthepmany S; Sorsavanh T; Siphanthong P; Sebert J; Viney K; Vixaysouk T; Nagai M; Seevisay V; Izumi K; Morishita F; Nishikiori N
    PLoS One; 2020; 15(11):e0241862. PubMed ID: 33180777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic evaluation of a shortened standardised treatment regimen of antituberculosis drugs for patients with multidrug-resistant tuberculosis (STREAM): study protocol.
    Gama E; Madan J; Langley I; Girma M; Evans D; Rosen S; Squire SB
    BMJ Open; 2016 Oct; 6(10):e014386. PubMed ID: 27798041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implementation of Xpert MTB/RIF for routine point-of-care diagnosis of tuberculosis at the primary care level.
    Clouse K; Page-Shipp L; Dansey H; Moatlhodi B; Scott L; Bassett J; Stevens W; Sanne I; Van Rie A
    S Afr Med J; 2012 Sep; 102(10):805-7. PubMed ID: 23034211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.